Rapid Oral Fluid Screening Devices Market to Top US$ 47.3 Billion with 7.1% CAGR by 2033: Fact.MR Report

Tuesday, September 19, 2023 at 8:00am UTC

Rockville , Sept. 19, 2023 (GLOBE NEWSWIRE) -- As per Fact.MR, a provider of market research and competitive intelligence, the global Rapid Oral Fluid Screening Devices Market is likely to increase at a CAGR of 7.1% to reach US $47.3 Bn by the end of 2033.

Rapid Oral Fluid Screening Devices are tools used to quickly check for drug use by testing a person's saliva. They are better than alternatives for several reasons. They are easy to use and don't require invasive procedures like collecting urine or pricking the skin for a blood sample. They give results right away, usually within a few minutes, which is crucial for situations where fast decisions are needed. Additionally, they are less likely to be tampered with compared to urine tests.

For More Insights into the Market, Request a Sample of this Report:

Key Segments of Rapid Oral Fluid Screening Devices Industry Research Report

By Drug TypeBy FormBy ProductBy End User
  • Alcohol
  • Marijuana (THC)
  • Opioids
  • Cocaine
  • Amphetamines
  • Methamphetamines
  • Benzodiazepines
  • Others
  • Cassettes
  • Swabs
  • Strips
  • 1-Panel Saliva Drug Test Kits
  • 4-Panel Saliva Drug Test Kits
  • 5-Panel Saliva Drug Test Kits
  • 6-Panel Saliva Drug Test Kits
  • 7-Panel Saliva Drug Test Kits
  • 8-Panel Saliva Drug Test Kits
  • 9-Panel Saliva Drug Test Kits
  • 10-Panel Saliva Drug Test Kits
  • 12-Panel Saliva Drug Test Kits
  • Hospitals
  • Diagnostic Laboratories
  • Forensic Laboratories
  • Private Employers
  • Home Care Settings

The growth of the Rapid Oral Fluid Screening Devices Market is primarily driven by the increasing demand for quick, non-invasive drug testing solutions across various sectors. These devices offer immediate results, making them essential in scenarios where swift decision-making is crucial, such as in workplaces and law enforcement.

Key Takeaways:

  • Market share of 6-panel Saliva drug test kits accounts for more than 25% of the global market.
  • Strips account is expected to account for the major share in the global rapid oral fluid screening devices market due to its highly portable nature and minimum inconvenience for the people being tested. Moreover, due to its cost-effective nature, it is a preferred choice over cassettes and swabs.
  • The United States is expected to witness good growth due to rising cases of drunk driving and opioid addiction.

“The Rapid Oral Fluid Screening Devices Market is driven by a surge in demand for non-invasive and immediate drug testing solutions, coupled with technological advancements and heightened accuracy of screening devices- Says Fact.MR Expert”

Report AttributesDetails
Forecast Period2023 – 2033
Value Projection (2033)US$ 47.3 Billion
Growth Rate (2023-2033)7.1% CAGR
No. of Pages170 pages
No. of Tables60 Tables
No. of Figures120 Figures

Get Customization on this Report for Specific Research Solutions:

Market Competition

The market shows a moderate level of competition, featuring prominent industry leaders like OraSure Technologies, Inc., Abbott Laboratories, Guangzhou Wondfo Biotech Co., Ltd, Oranoxis Inc., and Securetec Detections-Systeme AG, among other notable players. Prominent manufacturers are dedicating resources to research and develop novel testing kits and solutions in response to the increasing global demand.

  • In December 2022, Roadside Assistance (RSA) announced the launch of Securetec Drugwipe 6s, a new drug-driving testing system that boasts enhanced portability, quicker results, and an expanded range of drugs tested.
  • In March 2021, Data Facts, a leading provider of domestic and international background screening solutions, unveiled a collaboration with Premier Biotech aimed at offering customers the latest advancements in rapid oral drug testing.

Due to an increase in demand worldwide, major producers of rapid oral fluid screening devices are investing in research to create and market novel testing kits and solutions. Start-ups that specialize in developing rapid oral fluid screening technology are also entering the market with their innovative equipment, which helps to address important problems including drug use while driving and substance misuse.

  • A new method has been created by Bloonics B.V., a start-up that creates diagnostic products for the detection of cannabinoid activity, and it claims to more precisely assess THC impairment levels. The LuciX technology was anticipated to evaluate the person's consumption of cannabis and assess the likelihood that they were impaired when the test was administered. Police and other authorities' use of roadside drug testing may be revolutionized by this technology.

Winning strategies

  • Improving testing devices in the market through research and development (R&D) is vital. This means making them more accurate, sensitive, and faster. Accuracy ensures reliable results, reducing errors. Increased sensitivity allows for the detection of even tiny amounts of substances, crucial for early intervention. Speed is essential for quick decision-making in urgent situations.
  • Entering new regions or countries with high demand for oral fluid screening devices in the market is a smart strategy. It means reaching untapped markets where these devices are needed, diversifying revenue sources, and potentially reducing costs. It also helps build partnerships, enhances brand reputation, and encourages innovation. In a nutshell, expanding into new regions with growth potential is a promising way to grow in this market.

Checkout More Related Studies Published by Fact.MR Research:

Oral Solid Dosage Pharmaceutical Market: The global oral solid dosage pharmaceutical market was valued at US$ 524.6 billion in 2021 and is expected to top US$ 1.03 trillion in value by the end of 2032, expanding rapidly at a CAGR of 6.4% over the 2022-2032 study period.

Oral Thin Films Market: The global oral thin films market is estimated to expand at a CAGR of 8.7%, jumping from a market valuation of US$ 3.12 billion in 2022 to US$ 7.19 billion by the end of 2032.

Oral & Topical Anaesthetics Market: The oral & topical anaesthetics market is expected to garner a market value of US$ 841 Million by the end of 2028. Europe is expected to possess 39% market share for oral & topical anaesthetics market in the forecast period 2018-2028.

About Us:

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Teamsales@factmr.com
Follow Us: LinkedIn | Twitter | Blog

Primary Logo